Medtronic received information via literature regarding (b)(6) woman with a history of coronary artery bypass grafting (cabg), arterial hypertension, diabetes, stroke who had been implanted with mosaic 19 mm valve in aortic position and hancock ii 25 mm bioprosthesis in mitral position.A mitral transcatheter valve in- valve was implanted (tviv) due to degenerated bioprosthesis in the mitral position with severe eccentric regurgitation.No additional adverse patient effects or product performance issues were reported.
|